Aerie Pharmaceuticals reported $49K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Aerie Pharmaceuticals AERI:US USD 49K 1000
Alimera Sciences ALIM:US USD 70K 0
Amarin AMRN:US USD 298.6M 3.94M
Bluebird Bio BLUE:US USD 829K 94K
Cara Therapeutics CARA:US USD 53K 0
Coherus Biosciences CHRS:US USD 7K 0
Endo International Ordinary Shares ENDP:US USD 63K 3K
Insmed INSM:US USD 1.22M 18K
Mirati Therapeutics MRTX:US USD 58K 2K
Novartis NOVN:VX USD 878.25M 11.75M
Ophthotech OPHT:US USD 121K 4K
Pacira Pharmaceuticals PCRX:US USD 46K 0
Regeneron Pharmaceuticals REGN:US USD 100K 0
Revance Therapeutics RVNC:US USD 82K 9K
Supernus Pharmaceuticals SUPN:US USD 54K 1000
Teva Pharmaceutical Industries TEVA:US USD 57M 0
Valeant Pharmaceuticals VRX:CN USD 10.39B 7M
Zoetis ZTS:US USD 5M 0